Nectar Lifesciences Ltd ADR NECLF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.41
- Day Range
- $0.41–0.42
- 52-Week Range
- $0.20–0.54
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $92.84 Mil
- Volume/Avg
- 0 / 0
Key Statistics
- Price/Earnings (Normalized)
- 94.04
- Price/Sales
- 0.46
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Nectar Lifesciences Ltd is an India-based pharmaceutical company. It is engaged in manufacturing specialized pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and finished dosage formulations. It operates in the business segment of Pharmaceuticals Products, The company's product includes cefixime trihydrate, cefdinir, cefprozil, cefoxitin sodium, cefpirome sulphate, and others. Geographically, it derives a majority of its revenue from India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,589
- Website
- https://www.neclife.com
Comparables
Valuation
|
Metric
|
NECLF
|
500288
|
506943
|
|---|---|---|---|
Price/Earnings (Normalized) | 94.04 | 34.56 | 54.46 |
Price/Book Value | 0.72 | 3.36 | 10.41 |
Price/Sales | 0.46 | 1.61 | 8.50 |
Price/Cash Flow | 24.10 | 32.77 | 41.34 |
Price/Earnings
NECLF
500288
506943
Financial Strength
|
Metric
|
NECLF
|
500288
|
506943
|
|---|---|---|---|
Quick Ratio | 0.38 | 0.95 | 1.81 |
Current Ratio | 1.37 | 2.23 | 2.74 |
Interest Coverage | 1.08 | 30.56 | 15.51 |
Quick Ratio
NECLF
500288
506943
Profitability
|
Metric
|
NECLF
|
500288
|
506943
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | — |
Return on Equity (Normalized) | — | — | — |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
NECLF
500288
506943
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Sgbtdzgr | Xbwdp | $71.2 Bil | |
ZTS
| Zoetis Inc Class A | Cbhqvycldq | Gyhr | $68.3 Bil | |
HLN
| Haleon PLC ADR | Lglmvkc | Jtz | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Ygpcwcd | Ktgl | $14.5 Bil | |
VTRS
| Viatris Inc | Yznrwhlbp | Bgy | $13.4 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Hprfqgdrm | Ytw | $11.9 Bil | |
CTLT
| Catalent Inc | Grcrhtklh | Zzpbzb | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Psfppqml | Xgz | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Jyxzmtfsd | Mzfq | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Xjywqmchx | Dvjvb | $3.5 Bil |